GENERIC ONCOLOGY STERILE INJECTABLES MARKET ANALYSIS

Generic Oncology Sterile Injectables Market, by Product Type (Chemotherapy (Alkylating Agents, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics, and Others), Monoclonal Antibodies, Cytokines, and Peptide Hormones), by Disease Indication (Ovarian Cancer, Breast Cancer, Lung Cancer, Pancreatic Cancer, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Jan 2020
Code : CMI562
Pages :151
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Generic Oncology Sterile injectables Market - Competitive Landscape

Key players operating in the global generic oncology sterile injectables market include Eli Lilly & Company, Biocon Ltd., Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and Pfizer Inc.